Europe's CHMP endorses clutch of new medicines including Astellas, J&J and Ipsen offerings
Fierce Pharma
JULY 26, 2024
While it may well be the dog days of summer, European drug regulators are showing no signs of slowing down in their review of new medicines and proposed label expansions. While it may well be the dog days of summer, European drug regulators are showing no signs of slowing down in their review of new medicines and proposed label expansions.
Let's personalize your content